Covance collaboration with NHS on phase I trials
Covance says its agreement with the Royal Liverpool and Broadgreen University Hospitals NHS Trust will improve drug development and bring drugs to market sooner.
Archives for January 23, 2013
Impax remains upbeat after NDA rejection
Impax Pharmaceuticals says it remains confident of resolving issues at its manufacturing facilities following the rejection of its Parkinson’s drug Rytary.
update
Asian competition and counterfeits top challenges for African drugmakers says FAPMA
‘Unfair competition’ from Asian drugmakers and the prevalence of counterfeits are among the challenges facing African manufacturers according to a new pan-African industry group set on fostering local production.
GSK Shifts Supplier Invoice Payment Timing, Business Forum Cries Foul
GlaxoSmithKline has decided to only make once-monthly payments to suppliers, which could increase the amount of time it takes a CRO, CMO or other supplier to be paid for its work.
Cost of dissolution testing for levothyroxine a small price to pay for quality says MHRA
The cost of proposed new tests designed to ensure levothyroxine tablet quality is a small price to pay for manufacturers to ensure patient safety says the UK MHRA.
UK Cell Therapy Trial Database to Help Advance Trials to Later Stages
The UK's cell therapy industry now has a database of all ongoing clinical trials in the country with the aim of expanding research partnerships and pushing more early-stage trials to later stages.